Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia
Elizabeth A. Morgan,
Mark N. Lee,
Daniel J. DeAngelo,
David P. Steensma,
Richard M. Stone,
Frank C. Kuo,
Jon C. Aster,
Christopher J. Gibson,
R. Coleman Lindsley
Affiliations
Elizabeth A. Morgan
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and; Elizabeth A. Morgan, Department of Pathology, Brigham and Women's Hospital, Amory 3, 75 Francis St, Boston, MA 02115; e-mail: .
Mark N. Lee
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and
Daniel J. DeAngelo
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
David P. Steensma
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Richard M. Stone
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Frank C. Kuo
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and
Jon C. Aster
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and
Christopher J. Gibson
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
R. Coleman Lindsley
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
